Skip to content

For sponsors · CROs

A trusted site for your next trial

Valencia Medical & Research Center partners with sponsors, CROs, and academic centers to conduct Phase II–III clinical trials in Miami — experienced staff, robust infrastructure, and the community relationships that make enrollment and retention real.

Reply time ≤ 1 business day

  • ACCEL Study: Chronic Idiopathic Constipation (Ages 18–80)

    Miami, FL · NCT07382167

    NOW ENROLLING
  • AIRITY Asthma Study

    Miami, FL · NCT07556159

    NOW ENROLLING
  • Your next trial here

    Phase II–III · Miami, Florida

The numbers your feasibility team asks about first.

Trial phases conducted
II–III
Specialty areas
15+
Exam rooms
5
FDA Form 483s received
0

Why sponsors choose VMRC

0 · FDA Form 483s received

Consistently strong FDA audit performance — no Form 483 ever received.

EN / ES · Recruitment & retention

Bilingual physicians and coordinators — consent, visits, and follow-up in the participant's own language.

II–III · Trial phases conducted

Purpose-equipped for Phase II–III visits, sample handling, and investigational product custody.

Experienced leadership

Every study runs under physicians who work the clinic floor — participant safety and data integrity are led in person, not delegated.

Inti Fernandez, M.D.

Inti Fernandez, M.D.

Principal Investigator

Judith Valencia, M.D.

Judith Valencia, M.D.

Sub-Investigator

See our providers and credentials

Recruitment & retention

Enrollment is where trials stall. Ours draws on a community that already knows and trusts the clinic.

  • The database

    HIPAA-compliant participant database rooted in Miami's diverse, largely Spanish-speaking community.

  • In their language

    Bilingual physicians and coordinators — consent, visits, and follow-up in the participant's own language.

  • Retention is care

    Retention built on the same relationships that drive enrollment: participants stay because they are cared for.

  • Zero Form 483s

    Consistently strong FDA audit performance — no Form 483 ever received.

  • GCP-certified

    GCP-certified investigators and coordinators.

  • Monitor-ready

    Clean, monitor-ready documentation and source data practices.

Clinical infrastructure

Purpose-equipped for Phase II–III visits, sample handling, and investigational product custody.

Exam rooms
5
Investigational product
Double-lock pharmacy
Infusion
Dedicated infusion chairs
Cardiac
12-lead ECG
Cold chain
−20 °C and −70 °C freezers
Storage
Temperature-controlled, monitored
  • AbbVie
  • Ardelyx
  • AstraZeneca
  • Chiesi
  • Shionogi
  • Iterum Therapeutics
  • Areteia Therapeutics
  • ATEA Pharmaceuticals
  • Ironwood Pharmaceuticals
  • Landos Biopharma
  • Duke University
  • Labcorp
  • IQVIA
  • PPD
  • Syneos Health
  • ICON
  • Medpace
  • Fortrea

Logos identify organizations VMRC has conducted studies with; they do not imply endorsement.

Inside the site

Our Miami facility — the same rooms your monitors will visit.

  • Reception and waiting area
  • Infusion room with branded wall
  • Consultation room
  • On-site laboratory station
  • Participant care
  • Clinic storefront in Miami

Site selection

Bring your protocol
to Miami

Send us your protocol synopsis and we will respond with feasibility, projected enrollment, and startup timelines.

Reply time ≤ 1 business dayGCP-certified investigators and coordinators.Miami, Florida

Sponsors & CROs — VMRC